Bio-Matrix Scientific Group Inc. (BMSN) News Nov 14, 2014,

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Bio-Matrix Scientific Group Inc. (BMSN) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on BMSN
No News currently available for BMSN
Advertisement
Other News on BMSN
FDA Issues IND Number for Regen BioPharma's dCellVax Therapeutic Application, a Proposed ... 10:06 a.m. Nov. 4, 2014 - GuruFocus.com
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 3:01 p.m. Aug. 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 8:40 a.m. May 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Regen Bio provides an update on IND 12:52 p.m. May 12, 2014 - Seeking Alpha
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 6:10 p.m. Feb. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: BIO-MATRIX SCIENTIFIC GROUP, INC. 2:51 p.m. Jan. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 11:52 a.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 1:00 p.m. July 31, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 10:02 a.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 9:49 a.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 9:42 a.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 12:07 p.m. May 17, 2013 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on BMSN
Regen BioPharma Provides Update on dCellVax Breast Cancer Immunotherapy 9:01 a.m. Aug. 1, 2014 - Marketwire
Bio-Matrix Scientific Group Inc. Subsidiary Regen BioPharma Inc. Collaborates on Research Paper Analyzing the Use of Gene Silencing in Heart Transplants 9:01 a.m. June 11, 2014 - Marketwire
Bio-Matrix Scientific Group, Inc. Sees 37% Increase In Share Price 9:52 a.m. May 13, 2014 - ACCESSWIRE
Regen BioPharma, a Majority Owned Subsidiary of Bio-Matrix Scientific Group, Provides Update on HemaXellerate I(TM) IND for Treatment of Drug Resistant Aplastic Anemia 11:32 a.m. May 12, 2014 - Marketwire
Bio-Matrix Scientific Group Inc. Announces Dividend Record Date to Receive Shares in Its Subsidiary Regen BioPharma, Inc. 2:54 p.m. March 6, 2014 - Marketwire
Regen BioPharma Announces HemaXellerate I(TM) Efficacy Data in Animal Model of Aplastic Anemia 9:35 a.m. Dec. 11, 2013 - Marketwire
Bio-Matrix Scientific Group's Regen BioPharma Retains Cook General Biotechnology for Contract Manufacturing of HemaXellerate I 10:36 a.m. Oct. 31, 2013 - Marketwire
New In-Depth Stock Reports on BMSN, CERP, NAMG and NVIV 12:03 a.m. Oct. 25, 2013 - ACCESSWIRE
Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders 2:12 p.m. Oct. 9, 2013 - Marketwire
Bio-Matrix Scientific Group's Subsidiary Regen BioPharma Enters Into Preclinical Trials Agreement for HemaXellerate I Covering Aplastic Anemia 7:01 a.m. Sept. 26, 2013 - Marketwire
Bio-Matrix Scientific Group's Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product 7:31 a.m. Sept. 25, 2013 - Marketwire
Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr. David Suhy to Regen BioPharma Inc.'s Scientific Advisor Board 9:07 a.m. Sept. 17, 2013 - Marketwire
Bio-Matrix Scientific Group Discusses Regen BioPharma's Cancer Immunotherapy Program 12:49 p.m. Aug. 16, 2013 - Marketwire
Regen BioPharma Inc. Licenses Cancer Gene Silencing Technology From Benitec BioPharma 8:48 a.m. Aug. 8, 2013 - Marketwire
Bio-Matrix Scientific Group Provides Update on Its Regen BioPharma's HemaXellerate I(TM) Clinical Program 1:37 p.m. July 31, 2013 - Marketwire
Bio-Matrix Scientific Group's Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program 7:30 a.m. June 7, 2013 - Marketwire
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 184

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 294

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 126

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring xAI's Ambitious Journey to Transform AI into Infrastructure

Updated Category News Views 247

Understanding xAI’s Vision for the Future of AI xAI is making headlines with its bold ambition to raise $15 billion, potentially valuing the company at a staggering $230 billion. This move marks a significant shift in how investments in artificial intelligence are considered. Traditionally, startup evaluations focused on immediate financial returns. However, xAI is...

Continue Reading
Wipro Partners with RELEX Solutions to Enhance Supply Chain

Updated Category News Views 60

Wipro Forms Strategic Alliance with RELEX Solutions Wipro Limited (NYSE: WIT), a prominent player in technology services and consulting, has announced a significant strategic partnership with RELEX Solutions. This collaboration aims to leverage advanced technology in supply chain and retail planning, marking an important step in enhancing operational efficiency for their...

Continue Reading
Aker ASA Unveils Comprehensive Annual Report for 2024

Updated Category News Views 364

Aker ASA Unveils Comprehensive Annual Report for 2024 Aker ASA, a prominent player in the maritime and energy sectors, is excited to share its Annual Report for 2024, showcasing not just its financial performance but also its dedication to sustainability. This document provides a robust overview of the company’s achievements and highlights significant environmental,...

Continue Reading
Revolutionizing Infrastructure Management with StackGen's AI Agents

Updated Category News Views 223

Transformative Power of AI in Infrastructure Management Artificial Intelligence (AI) is reshaping the way businesses operate, particularly in the realm of infrastructure management. StackGen, a trailblazer in autonomous infrastructure technology, has unveiled its groundbreaking Autonomous Infrastructure Platform. This innovative platform leverages AI agents designed to...

Continue Reading
Ensurge Micropower Successfully Raises NOK 100 Million in Shares

Updated Category News Views 270

Ensurge Micropower Successfully Completes Private Placement Ensurge Micropower ASA has announced the successful placement of its private placement, which has raised an impressive gross amount of NOK 100 million. This substantial financing comes from the allocation of 83,678,032 shares in Tranche 1, along with a conditional allocation of 27,433,079 shares in Tranche 2. All...

Continue Reading